Michael Catelani
Patrimonio netto: 120 150 $ in data 31/05/2026
Patrimonio netto: 120 150 $ in data 31/05/2026
Mr. Michael J.
Catelani is a President, COO, CFO & Secretary at Anixa Biosciences, Inc. Mr. Catelani was previously employed as a Chairman, President & Chief Financial Officer by Tacere Therapeutics, Inc., a Chief Financial Officer & Director by Benitec Ltd. (Australia), a Chief Financial Officer & Vice President by Axon Instruments, Inc., a Vice President-Finance by Media Arts Group, Inc., a Controller, Project Manager-Research & Development by Airtox, Inc., a Principal by Ernst & Young LLP (Missouri), and a Treasurer & Director by InnVision the Way Home.
He also served on the board at PRC Clinical.
He received his undergraduate degree from California State University-Sacramento and an MBA from the University of California, Davis.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 13/01/2026 | 44.500 ( 0,13% ) | 120 150 $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| ANIXA BIOSCIENCES, INC. | Direttore Finanziario/CFO | 01/11/2016 |
| Società | Posizione | Fine |
|---|---|---|
PRC Clinical
PRC Clinical Miscellaneous Commercial ServicesCommercial Services Provides clinical trial management services | Direttore/Membro del Consiglio | 01/07/2017 |
Tacere Therapeutics, Inc.
Tacere Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic drugs | Fondatore | 01/10/2012 |
Benitec Biopharma Pty Ltd.
Benitec Biopharma Pty Ltd. BiotechnologyHealth Technology Operates as a biotechnology, research and development company | Direttore Finanziario/CFO | 22/06/2006 |
Axon Instruments, Inc.
Axon Instruments, Inc. Medical SpecialtiesHealth Technology Manufactures instruments and software for drug discovery and academic research | Direttore Finanziario/CFO | 01/01/2004 |
Media Arts Group, Inc.
Media Arts Group, Inc. Home FurnishingsConsumer Durables Designs, manufactures, and markets artistic products | Direttore Finanziario/CFO | 01/01/2001 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 11 |
|---|---|
Anixa Biosciences, Inc.
Anixa Biosciences, Inc. BiotechnologyHealth Technology Develops therapies and vaccines for oncology and infectious disease | Health Technology |
Media Arts Group, Inc.
Media Arts Group, Inc. Home FurnishingsConsumer Durables Designs, manufactures, and markets artistic products | Consumer Durables |
Tacere Therapeutics, Inc.
Tacere Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic drugs | Health Technology |
Ernst & Young LLP (Missouri)
Ernst & Young LLP (Missouri) Miscellaneous Commercial ServicesCommercial Services Provides accounting, audit, tax and business consulting services | Commercial Services |
Benitec Biopharma Pty Ltd.
Benitec Biopharma Pty Ltd. BiotechnologyHealth Technology Operates as a biotechnology, research and development company | Health Technology |
Axon Instruments, Inc.
Axon Instruments, Inc. Medical SpecialtiesHealth Technology Manufactures instruments and software for drug discovery and academic research | Health Technology |
California State University-Sacramento
California State University-Sacramento Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Davis
University of California, Davis Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Airtox, Inc.
Airtox, Inc. Miscellaneous Commercial ServicesCommercial Services Provides creative, customized, defensible solutions for air testing | Commercial Services |
InnVision the Way Home
InnVision the Way Home Services to the Health IndustryHealth Services Provides housing assistance services | Health Services |
PRC Clinical
PRC Clinical Miscellaneous Commercial ServicesCommercial Services Provides clinical trial management services | Commercial Services |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale